Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced

Xiaoyan Fu1, Jiyu Ju1, Zhijuan Lin1

  • 1Key Lab for Immunology in Universities of Shandong Province, School of Clinical Medicine, Weifang Medical University, Weifang, 261053, P.R.China.

Scientific Reports
|July 23, 2016
PubMed

Insights

Scientists generated C9-deficient mice to study the membrane attack complex (MAC). These mice showed reduced hemolysis and LPS-induced shock, highlighting MAC

Area of Science:

  • Immunology
  • Complement system
  • Molecular biology

Background:

  • The terminal complement cascade forms the membrane attack complex (MAC), C5b-9, which can lyse cells.
  • Previous studies on MAC function used C5 or C6 deficient mice or CD59 regulators.
  • A C9-deficient mouse model was lacking to specifically investigate the role of C5b-9.

Purpose of the Study:

  • To generate and characterize a mouse model deficient in C9 (mC9(-/-)).
  • To dissect the specific role of C5b-9 in complement-mediated hemolysis and disease pathogenesis.
  • To investigate the involvement of C5b-9 in inflammasome activation.

Main Methods:

  • Generation of C9-deficient mice (mC9(-/-)).
  • Assessment of anti-erythrocyte antibody-mediated hemolysis in mC9(-/-) mice.
  • Evaluation of lipopolysaccharide (LPS)-induced acute shock and IL-1β release in mC9(-/-) mice.

Main Results:

  • The generated mC9(-/-) mice successfully lacked C9.
  • Absence of C9 significantly attenuated anti-erythrocyte antibody-mediated hemolysis.
  • mC9(-/-) mice exhibited reduced severity of LPS-induced acute shock, correlating with decreased IL-1β release and suppressed MAC-mediated inflammasome activation.

Conclusions:

  • The study successfully generated mC9(-/-) mice, providing a valuable tool to study MAC function.
  • Results confirm the critical role of C5b-9 in complement-mediated hemolysis.
  • The findings highlight the significant involvement of C5b-9 in inflammasome activation and associated pathologies.